Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Discover actionable methods to keep your spending in check and ensure your budget supports both short-term needs and long-term goals.
17,745 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
With Netflix's investor update looming, investors wonder whether to buy before the release. This guide breaks down st...
Sirius XM stunned investors with a near-50% rise in the first half of 2026. This analysis breaks down the catalysts, ...
A drone leader sparked fresh optimism as AeroVironment stock took flight this week, jumping on news of real-world cou...
When big funds hold IonQ, retail investors often assume a sure bet. The reality is more nuanced: ownership data refle...
Is Bloom Energy a buy, sell, or hold in 2026? This guide breaks down the business, potential catalysts, and key risks...
Palantir stock just popped on fresh bullish whispers and government momentum. This guide breaks down the drivers, ris...
When a chief executive sells stock after exercising options, investors often wonder if confidence underpins the move....
Costco's stock keeps breaking the $1,000 threshold, fueling split rumors. This guide unpacks why the price stays high...
SpaceX is often defined by rockets and AI, but the real engine of growth sits in how it monetizes orbit-enabled infra...
A quiet strategic shift could power ELF's growth without fanfare. This article breaks down what the move is, why it m...
Webull trades in the mid-$6s as analysts outline a possible 50% jump within 12 months, driven by stronger revenue, ex...